Stay updated with breaking news from Eric Zi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...
Venus Medtech ( Hangzhou ) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve),
HANGZHOU, China, Dec. 8, 2021 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its
JERUSALEM, Dec. 8 (Xinhua) -- Chinese heart disease treatment company Venus Medtech has acquired the Israeli company Cardiovalve for 300 million U.S. dollars, b
Share this article Share this article HANGZHOU, China, July 27, 2021 /PRNewswire/ -- On July 27, 2021, Venus Medtech (Hangzhou) Inc. ("Venus Medtech") (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions in China, and its controlling subsidiary Renaly Ltd., announced that Professor Martin B. Leon, MD, a pioneer in the field of interventional cardiovascular devices, has been appointed as the Global Principal Investigator (PI) for its new-generation renal artery denervation (RDN) system. (PRNewsfoto/杭州启明医疗器械股份有限公司...